Search results
Get the latest iBio, Inc. (IBIO) stock news and headlines to help you in your trading and investing decisions.
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.
The latest messages and market ideas from IBIO (@iBio_millionaire) on Stocktwits. The largest community for investors and traders ... iBio_millionaire. IBIO. Follow ...
At close: 04:00PM EDT. 2.3007 -0.03 (-1.26%) After hours: 07:34PM EDT. Find the latest iBio, Inc. (IBIO) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.
4 days ago · iBio saw a drop in short interest in April. As of April 30th, there was short interest totaling 135,200 shares, a drop of 26.7% from the April 15th total of 184,500 shares. Based on an average daily trading volume, of 3,740,000 shares, the short-interest ratio is presently 0.0 days. Approximately 1.6% of the company's stock are short sold.
The latest messages and market ideas from Sam Buemi (@iBio_Cultist) on Stocktwits. Base decisions off the weight of the evidence.
Stocktwits provides real-time stock, crypto & international market data to keep you up-to-date. Find top news headlines, discover your next trade idea, share & gain insights from traders and investors from around the world, build a watchlist, buy US stocks, & create and manage your portfolio.
